Michelle Haber

Cancer Institute (WIA) — India

Medicine · Health Sciences

65h-index16.4kcitations660works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(325), Acute Lymphoblastic Leukemia research(81), Cancer, Hypoxia, and Metabolism(75), Cancer therapeutics and mechanisms(74), Protein Degradation and Inhibitors(63)

Publications657 total

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma
Science Advances·2025Open Access
P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma
EJC Paediatric Oncology·2025· 1 citedOpen Access
Data Sharing, Biopsies and Patient Confidentiality in a Precision Medicine Trial for Childhood Cancer: A Mixed Method Study of Parents, Oncologists, and Scientists’ Perspectives
Journal of Personalized Medicine·2025Open Access
Abstract B079: The glycogen synthase kinase-3β inhibitor 9-ING-41 in combination with chemoimmunotherapy provides long-term survival in the Th-MYCN mouse model
Molecular Cancer Therapeutics·2025
Abstract A001-PR009: Whole-genome-based, tumor-informed circulating tumor DNA detection correlates with treatment response and survival of pediatric solid tumor
Cancer Research·2025
Abstract A002-PR011: Precision Diagnosis in High-Risk Pediatric Oncology through Integrated Whole Genome, Transcriptome, and Epigenome Profiling
Cancer Research·2025
Abstract A045: Cooperation between germline and somatic drivers in childhood cancer: insights from the ZERO cohort
Cancer Research·2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
Journal of Experimental & Clinical Cancer Research·2025Open Access
Immune Response to COVID-19 Vaccination in Children With Cancer
PEDIATRICS·2025Open Access
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity
2025· 1 citedOpen Access
Figure S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Figure 5 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Table S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Figure S4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Data from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Figure S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Figure S3 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Figshare·2025Open Access
Figure 4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Table S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
Table 1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025Open Access
page 1 of 33Next →

Frequent Co-authors

Murray D. Norris(39), Glenn M. Marshall(23), Tao Liu(10), Michelle J. Henderson(9), Claudia L. Flemming(9), Susan L. Cohn(8), Jayne Murray(7), Chelsea Mayoh(7), Wendy B. London(7), Belamy B. Cheung(7), Giovanni Perini(7), Jamie I. Fletcher(6), Maria Kavallaris(6), Catherine A. Burkhart(5), Emanuele Valli(5), Andrew J. Gifford(5), Toby N. Trahair(5), David S. Ziegler(5), Janice Smith(5), Bing Liu(5)